Protembis raised €30M in a Series B round in Mar 2024. The company is based in Aachen, Germany. Investors in the round: Coparion, Family Offices, Segulah Medical Acceleration and 2 others. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €30M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
